CN Patent

CN104379162A — 用于治疗蓬佩氏病的方法和材料

Assigned to Oxyrane UK Ltd · Expires 2015-02-25 · 11y expired

What this patent protects

本文件涉及具有酸性alpha葡糖苷酶活性和至少一处修饰的分子复合物，所述修饰导致分子复合物被转运到哺乳动物细胞内部的能力增强。

USPTO Abstract

本文件涉及具有酸性alpha葡糖苷酶活性和至少一处修饰的分子复合物，所述修饰导致分子复合物被转运到哺乳动物细胞内部的能力增强。

Drugs covered by this patent

Patent Metadata

Patent number
CN104379162A
Jurisdiction
CN
Classification
—
Expires
2015-02-25
Drug substance claim
No
Drug product claim
No
Assignee
Oxyrane UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.